NYSE · CIK 0002039497
RHLD Resolute Holdings Management, Inc.
Insider trading from SEC Form 4. Last filing Aug 24, 2026. Close $118.17 on Oct 9, 2026, +62% from the 52-week low and -48% from the high.
In brief
Resolute Holdings Management, Inc. (RHLD) has 41 SEC Form 4 filings on file from 12 insiders, the latest filed on Aug 24, 2026. In the last 90 days insiders made 1 open-market buy worth $44k and 0 open-market sells worth $0, net +$44k.
10 open-market trades have been scored at RHLD. The newest: Kurt Schoen (Chief Financial Officer) bought $44k of stock on Aug 20, 2026, filed Aug 24, 2026, scored 34 (weak). The largest of the 10 shown: Timothy O. Mahoney (director) bought $1.0M on Nov 7, 2025, scored 56 (moderate). 2 insiders bought within 14 days of each other around May 14, 2026.
2 Form 144 notices of planned sales are on file, the latest filed Mar 17, 2026.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Resolute Holdings Management, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 34Weak | Kurt Schoen Chief Financial Officer buy | $44k 375 shares | +13% | +118% from low-45% from high | |
| 51Moderate | Krishna Mikkilineni director buy | $100k 921 shares | +411% | +287% from low-53% from high | |
| 53Moderate | Kurt Schoen Chief Financial Officer buy | $49k 450 shares | +19% | +284% from low-53% from high | |
| 48Moderate | John D. Cote director buy | $79k 552 shares | - | +485% from low-36% from high | |
| 52Moderate | Kurt Schoen Chief Financial Officer buy | $71k 500 shares | +26% | +485% from low-36% from high | |
| 33Weak | Jane J. Thompson director sell | $230k 1,850 shares | -23% | +485% from low-36% from high | |
| 56Moderate | Timothy O. Mahoney director buy | $500k 3,268 shares | +55% | - | |
| 56Moderate | Kurt Schoen Chief Financial Officer buy | $134k 900 shares | +90% | - | |
| 56Moderate | Timothy O. Mahoney director buy | $1.0M 5,939 shares | - | - | |
| 49Moderate | Kurt Schoen Chief Financial Officer buy | $165k 1,000 shares | - | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 17, 2026 | THOMPSON JANE J. Officer | 1,850 0.02% of outstanding | $230k | Mar 17, 2026 | none |
| Mar 17, 2025 | Fitzsimmons Timothy Walter Director, 10% Stockholder, control | 10,000 0.12% of outstanding | $319k | Mar 14, 2025 | none |
Transactions
The newest 50 of 59 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | Kurt Schoen Chief Financial Officer | POpen-market purchase Common Stock, par value $0.0001 per share | +375 | $117.84 | $44k | 3,225 | Aug 24, 2026 |
| Jun 11, 2026 | Timothy O. Mahoney director | AGrant or award Stock Option (Right to Buy)derivative | +3,630 | $0.00 | $0 | 3,630 | Jun 15, 2026 |
| Jun 11, 2026 | Roger Fradin director | AGrant or award Stock Option (Right to Buy)derivative | +1,452 | $0.00 | $0 | 1,452 | Jun 15, 2026 |
| Jun 11, 2026 | John D. Cote director | AGrant or award Stock Option (Right to Buy)derivative | +1,452 | $0.00 | $0 | 1,452 | Jun 15, 2026 |
| Jun 11, 2026 | Brian F. Hughes director | AGrant or award Stock Option (Right to Buy)derivative | +1,452 | $0.00 | $0 | 1,452 | Jun 15, 2026 |
| Jun 11, 2026 | Mark R. James director | AGrant or award Stock Option (Right to Buy)derivative | +1,452 | $0.00 | $0 | 1,452 | Jun 15, 2026 |
| Jun 11, 2026 | Paul Galant director | AGrant or award Stock Option (Right to Buy)derivative | +1,452 | $0.00 | $0 | 1,452 | Jun 15, 2026 |
| Jun 11, 2026 | Krishna Mikkilineni director | AGrant or award Stock Option (Right to Buy)derivative | +1,452 | $0.00 | $0 | 1,452 | Jun 15, 2026 |
| Jun 11, 2026 | Wayne M. Hewett director | AGrant or award Stock Option (Right to Buy)derivative | +3,630 | $0.00 | $0 | 3,630 | Jun 15, 2026 |
| Jun 11, 2026 | Joseph J Deangelo director | AGrant or award Stock Option (Right to Buy)derivative | +1,452 | $0.00 | $0 | 1,452 | Jun 15, 2026 |
| Jun 11, 2026 | Jane J. Thompson director | AGrant or award Stock Option (Right to Buy)derivative | +1,452 | $0.00 | $0 | 1,452 | Jun 15, 2026 |
| Jun 11, 2026 | Timothy O. Mahoney director | AGrant or award Stock Option (Right to Buy)derivative | +726 | $0.00 | $0 | 726 | Jun 15, 2026 |
| Jun 11, 2026 | Wayne M. Hewett director | AGrant or award Stock Option (Right to Buy)derivative | +726 | $0.00 | $0 | 726 | Jun 15, 2026 |
| May 14, 2026 | Krishna Mikkilineni director | POpen-market purchase Common Stock, par value $0.0001 per share | +921 | $108.52 | $100k | 1,145 | May 15, 2026 |
| May 13, 2026 | Kurt Schoen Chief Financial Officer | POpen-market purchase Common Stock, par value $0.0001 per share | +450 | $108.34 | $49k | 2,850 | May 15, 2026 |
| Mar 17, 2026 | John D. Cote director | POpen-market purchase Common Stock, par value $0.0001 per shareindirect: By Spouse | +261 | $141.66 | $37k | 261 | Mar 18, 2026 |
| Mar 17, 2026 | Kurt Schoen Chief Financial Officer | POpen-market purchase Common Stock | +500 | $141.51 | $71k | 2,400 | Mar 18, 2026 |
| Mar 17, 2026 | Jane J. Thompson director | SOpen-market sale Common Stock, par value $0.0001 per share | -1,850 | $124.42 | $230k | 6,273 | Mar 18, 2026 |
| Mar 17, 2026 | John D. Cote director | POpen-market purchase Common Stock, par value $0.0001 per shareindirect: By Spouse | +239 | $142.50 | $34k | 500 | Mar 18, 2026 |
| Mar 17, 2026 | John D. Cote director | POpen-market purchase Common Stock, par value $0.0001 per shareindirect: By Spouse | +52 | $144.50 | $7,514 | 552 | Mar 18, 2026 |
| Nov 18, 2025 | Timothy O. Mahoney director | POpen-market purchase Common Stock | +3,268 | $152.98 | $500k | 9,207 | Nov 20, 2025 |
| Nov 18, 2025 | Kurt Schoen Chief Financial Officer | POpen-market purchase Common Stock | +900 | $149.23 | $134k | 1,900 | Nov 20, 2025 |
| Nov 7, 2025 | Timothy O. Mahoney director | POpen-market purchase Common Stock | +350 | $162.23 | $57k | 350 | Nov 12, 2025 |
| Nov 7, 2025 | Kurt Schoen Chief Financial Officer | POpen-market purchase Common Stock | +1,000 | $164.95 | $165k | 1,000 | Nov 12, 2025 |
| Nov 7, 2025 | Timothy O. Mahoney director | POpen-market purchase Common Stock | +115 | $164.23 | $19k | 465 | Nov 12, 2025 |
| Nov 7, 2025 | Timothy O. Mahoney director | POpen-market purchase Common Stock | +91 | $165.26 | $15k | 556 | Nov 12, 2025 |
| Nov 7, 2025 | Timothy O. Mahoney director | POpen-market purchase Common Stock | +364 | $166.72 | $61k | 920 | Nov 12, 2025 |
| Nov 7, 2025 | Timothy O. Mahoney director | POpen-market purchase Common Stock | +876 | $167.83 | $147k | 1,796 | Nov 12, 2025 |
| Nov 7, 2025 | Timothy O. Mahoney director | POpen-market purchase Common Stock | +2,234 | $168.95 | $377k | 4,030 | Nov 12, 2025 |
| Nov 7, 2025 | Timothy O. Mahoney director | POpen-market purchase Common Stock | +1,512 | $170.08 | $257k | 5,542 | Nov 12, 2025 |
| Nov 7, 2025 | Timothy O. Mahoney director | POpen-market purchase Common Stock | +397 | $170.94 | $68k | 5,939 | Nov 12, 2025 |
| Jul 17, 2025 | Wayne M. Hewett director | AGrant or award Stock Option (Right to Buy)derivative | +2,185 | - | - | 2,185 | Jul 17, 2025 |
| Jul 16, 2025 | Timothy O. Mahoney director | AGrant or award Stock Option (Right to Buy)derivative | +2,449 | - | - | 2,449 | Jul 17, 2025 |
| Jul 12, 2025 | Wayne M. Hewett director | AGrant or award Stock Option (Right to Buy)derivative | +21,731 | $0.00 | $0 | 21,731 | Jul 15, 2025 |
| Jul 12, 2025 | Timothy O. Mahoney director | AGrant or award Stock Option (Right to Buy)derivative | +21,731 | $0.00 | $0 | 21,731 | Jul 15, 2025 |
| May 28, 2025 | John D. Cote director, owner | AGrant or award Stock Option (Right to Buy)derivative | +5,603 | $0.00 | $0 | 5,603 | May 30, 2025 |
| May 28, 2025 | Joseph J Deangelo director | AGrant or award Stock Option (Right to Buy)derivative | +5,603 | $0.00 | $0 | 5,603 | May 30, 2025 |
| May 28, 2025 | Roger Fradin director | AGrant or award Stock Option (Right to Buy)derivative | +5,603 | $0.00 | $0 | 5,603 | May 30, 2025 |
| May 28, 2025 | Paul Galant director | AGrant or award Stock Option (Right to Buy)derivative | +5,603 | $0.00 | $0 | 5,603 | May 30, 2025 |
| May 28, 2025 | Brian F. Hughes director | AGrant or award Stock Option (Right to Buy)derivative | +5,603 | $0.00 | $0 | 5,603 | May 30, 2025 |
| May 28, 2025 | Mark R. James director | AGrant or award Stock Option (Right to Buy)derivative | +5,603 | $0.00 | $0 | 5,603 | May 30, 2025 |
| May 28, 2025 | Krishna Mikkilineni director | AGrant or award Stock Option (Right to Buy)derivative | +5,603 | $0.00 | $0 | 5,603 | May 30, 2025 |
| May 28, 2025 | Jane J. Thompson director | AGrant or award Stock Option (Right to Buy)derivative | +5,603 | $0.00 | $0 | 5,603 | May 30, 2025 |
| Feb 28, 2025 | David M Cote Executive Chairman | AGrant or award Common Stock, par value $0.0001 per shareindirect: By spouse | +1,866 | - | - | 1,866 | Mar 4, 2025 |
| Feb 28, 2025 | John D. Cote director, owner | AGrant or award Common Stock, par value $0.0001 per shareindirect: By Resolute Compo Holdings LLC | +4,107,534 | - | - | 4,107,534 | Mar 4, 2025 |
| Feb 28, 2025 | Mark R. James director | AGrant or award Common Stock, par value $0.0001 per shareindirect: By Mark R James Revocable Trust | +1,797 | - | - | 1,797 | Mar 4, 2025 |
| Feb 28, 2025 | Brian F. Hughes director | AGrant or award Common Stock, par value $0.0001 per share | +7,858 | - | - | 7,858 | Mar 4, 2025 |
| Feb 28, 2025 | Paul Galant director | AGrant or award Common Stock, par value $0.0001 per share | +7,690 | - | - | 7,690 | Mar 4, 2025 |
| Feb 28, 2025 | Roger Fradin director | AGrant or award Stock Option (Right to Buy)derivative | +2,064 | $0.00 | $0 | 2,064 | Mar 4, 2025 |
| Feb 28, 2025 | Joseph J Deangelo director | AGrant or award Stock Option (Right to Buy)derivative | +2,064 | $0.00 | $0 | 2,064 | Mar 4, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- David M CoteExecutive Chairman
- John D. Cotedirector, owner
- Joseph J Deangelodirector
- Roger Fradindirector
- Paul Galantdirector
- Wayne M. Hewettdirector
- Brian F. Hughesdirector
- Mark R. Jamesdirector
- Timothy O. Mahoneydirector
- Krishna Mikkilinenidirector
- Kurt SchoenChief Financial Officer
- Jane J. Thompsondirector
Questions about RHLD
Answered from the filings on this page, as of the latest one.
Are insiders buying RHLD?
As of Aug 24, 2026, SEC Form 4 filings show 1 open-market buy worth $44k by 1 insider and 0 open-market sells worth $0 by 0 insiders at Resolute Holdings Management, Inc. in the last 90 days, net +$44k. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade RHLD on the open market?
Kurt Schoen (Chief Financial Officer) bought $44k of RHLD on Aug 20, 2026 and filed the Form 4 on Aug 24, 2026. InsiderTell scored 34 (weak).
How many insiders file Form 4 at Resolute Holdings Management, Inc.?
12 people have filed a Form 4 at Resolute Holdings Management, Inc., among them David M Cote (Executive Chairman), John D. Cote (director and 10% owner), Joseph J Deangelo (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.